This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Noble, R. L. Articles by Gout, P. W. Search for Related Content PubMed PubMed Citation Articles by Noble, R. L. Articles by Gout, P. W.

Evidence in Vivo and in Vitro of a Role for the Pituitary in the Growth of Malignant Lymphomas in Nb Rats¹

Department of Cancer Endocrinology, Cancer Control Agency of British Columbia, 2656 Heather Street, Vancouver V5Z 3J3 [R. L. N.], and Department of Biochemistry, The University of British Columbia, Vancouver, V6T 1W5 [C. T. B., P. W. G.], British Columbia, Canada

The growth of a transplantable malignant lymphoma in Nb rats, the Nb 2 node, was accelerated in rats bearing an estrogen pellet and, in particular, in rats bearing transplanted tumors of the anterior pituitary gland. "Lymphoma cell growth-promoting activity" in the sera from the rats was detected and assayed using cultures of Nb 2 node cells. The "activity" of the sera paralleled the degree to which lymphoma growth was accelerated in the animals. Serum from normal rats at a concentration of 1% was moderately active in stimulating culture growth; serum from estrogenized rats was at least 10 times more active; serum from rats bearing pituitary tumors was extremely active and stimulated growth even at a concentration of 0.001% (1:10⁵ dilution). In contrast, serum from hypophysectomized rats was devoid of activity, even if the animals were estrogenized. The evidence indicates (a) that the growth of the lymphoma in Nb rats was stimulated by factor(s) in the peripheral blood, the levels of which were subject to control by the pituitary, and (b) that estrogen stimulated lymphoma growth indirectly, through the pituitary gland.

¹ Supported by grants from the National Cancer Institute of Canada, the Medical Research Council of Canada, and the Vancouver Foundation, British Columbia, Canada. Some of the data were presented at the 70th Annual Meeting of the American Association for Cancer Research (2).

² Career Investigator of the Medical Research Council of Canada.

Received 12/19/79. Accepted 4/14/80.

This article has been cited by other articles:

				M. A. Rycyzyn, S. C. Reilly, K. O’Malley, and C. V. Clevenger Role of Cyclophilin B in Prolactin Signal Transduction and Nuclear Retrotranslocation Mol. Endocrinol., August 1, 2000; 14(8): 1175 - 1186. [Abstract] [Full Text]

				C. V. Clevenger, W. Ngo, D. L. Sokol, S. M. Luger, and , A. M. Gewirtz Vav Is Necessary for Prolactin-stimulated Proliferation and Is Translocated into the Nucleus of a T-cell Line J. Biol. Chem., June 2, 1995; 270(22): 13246 - 13253. [Abstract] [Full Text] [PDF]

				C. Clevenger, S. Altmann, and M. Prystowsky Requirement of nuclear prolactin for interleukin-2--stimulated proliferation of T lymphocytes Science, July 5, 1991; 253(5015): 77 - 79. [Abstract] [PDF]